US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

abrdn Life Sciences Investors

us-stock
To Invest in {{usstockname}}
us-stock
$17.12 0.0124(1.24%) HQL at 04 Dec 2025 04:34 PM Asset Management
Lowest Today 16.94
Highest Today 17.12
Today’s Open 16.95
Prev. Close 16.91
52 Week High 17.70
52 Week Low 9.59
Day’s Range: Low 16.94 High 17.12
52-Week Range: Low 9.59 High 17.70
1 day return -
1 Week return -3.22
1 month return +2.82
3 month return +20.79
6 month return +35.98
1 year return +20.02
3 year return +14.4
5 year return -9.53
10 year return -

Institutional Holdings

Market Status

Fundamentals

Market Cap 488.23 M

PB Ratio 1.2885

PE Ratio 0.0

Enterprise Value 488.23 M

Total Assets 460.58 M

Volume 88929

Company Financials

Annual Revenue FY24:86685230 86.7M, FY23:23523699 23.5M, FY22:-103250433 -103.3M, FY21:65688448 65.7M, FY20:124082979 124.1M

Annual Profit FY24:86685230 86.7M, FY23:23523699 23.5M, FY22:-103250433 -103.3M, FY21:65688448 65.7M, FY20:124082979 124.1M

Annual Net worth FY24:85296459 85.3M, FY23:22352248 22.4M, FY22:-104603100 -104.6M, FY21:64530743 64.5M, FY20:123053000 123.1M

Quarterly Revenue Q1/2025:18198713 18.2M, Q3/2024:1914720 1.9M, Q1/2024:2065264 2.1M, Q4/2023:1032632 1.0M, Q3/2023:29564128 29.6M

Quarterly Profit Q1/2025:null 0.0M, Q3/2024:1914720 1.9M, Q1/2024:2065264 2.1M, Q4/2023:1032632 1.0M, Q3/2023:26973758 27.0M

Quarterly Net worth Q1/2025:-47234264 -47.2M, Q3/2024:35040014 35.0M, Q1/2024:50256446 50.3M, Q4/2023:25128223 25.1M, Q3/2023:-11450705 -11.5M

Fund house & investment objective

Company Information Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Organisation Asset Management

Employees 0

Industry Asset Management

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right